Nucleoid as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma
Status:
Unknown status
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the investigators' study is to prospectively evaluate whether nucleoid
antiviral therapy will improve the outcome of radiofrequency ablation for hepatocellular
carcinoma (HCC).